Idexx Laboratories (IDXX) Shares Outstanding (2009 - 2026)

Idexx Laboratories has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $78.9 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 1.59% year-over-year to $78.9 million in Q2 2026; TTM through Jun 2026 was $78.9 million, a 1.59% decrease from a year earlier, with the FY2025 full-year figure at $79.7 million, down 2.32% from the prior year.
• Shares Outstanding (Entity) was $78.9 million for Q2 2026 at Idexx Laboratories, roughly flat from $79.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $84.2 million in Q1 2022, with the low at $78.9 million in Q2 2026.
• Average Shares Outstanding (Entity) over 5 years is $81.9 million, with a median of $82.7 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) climbed 0.17% in 2023, then declined 2.82% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $82.9 million in 2022, then rose by 0.17% to $83.0 million in 2023, then fell by 1.72% to $81.6 million in 2024, then declined by 2.32% to $79.7 million in 2025, then retreated by 1.05% to $78.9 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $78.9 million (Q2 2026), $79.2 million (Q1 2026), and $79.7 million (Q4 2025), per Business Quant data.